Codeveloping a Novel Intervention to Promote the Well-Being of Family Caregivers of Individuals With Spinal Cord Injury: Protocol for a Feasibility Randomized Control Trial

共同开发一种促进脊髓损伤患者家庭照护者福祉的新型干预措施:可行性随机对照试验方案

阅读:1

Abstract

BACKGROUND: Family caregivers of individuals with spinal cord injury (fcSCI) provide assistance with activities of daily living for individuals with spinal cord injury (SCI), which can include emotional support and physical assistance. Over time, providing daily support can put fcSCI at risk of experiencing caregiver burden. This burden can have a substantial impact on fcSCI's well-being. A direct predictor of the fcSCI burden is their appraisal of their ability to cope with the individual with SCI. Therefore, supporting fcSCI's access to education relevant to their role and the health and well-being of the individual with SCI can help decrease this burden. OBJECTIVE: The purpose of this study is to evaluate the fidelity of the COMPANION intervention and its study protocol designed to improve outcomes for fcSCI. METHODS: Recruitment began in June 2024 and is ongoing. Data collection was completed in April 2025. The fcSCI randomized into the intervention group have been given access to COMPANION after randomization. Data collection for both participant groups (COMPANION and control) will be performed after randomization and will be performed again after 3 months (T2) and 6 months (T3) to capture the impact of COMPANION on fcSCI's psychological well-being. RESULTS: As of June 2024, recruitment has begun and is ongoing. Data collection has begun and will conclude in 2025. The fcSCI randomized into the intervention group have been given access to COMPANION after randomization. Data collection for both participant groups (COMPANION and control) is collected after randomization, and again after three months (T2) and six months (T3) to capture the impact of COMPANION on fcSCI's psychological wellbeing. CONCLUSIONS: Study results will evaluate whether the full study can and should be conducted and will lead to the refinement of COMPANION. TRIAL REGISTRATION: ClinicalTrials.gov NCT06364813; https://clinicaltrials.gov/study/NCT06364813. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/67709.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。